Acute Pulmonary Oedema David Lightfoot 07 00 at

  • Slides: 39
Download presentation
Acute Pulmonary Oedema David Lightfoot

Acute Pulmonary Oedema David Lightfoot

07. 00 at a Monash. Health ED near you when…. .

07. 00 at a Monash. Health ED near you when…. .

Its the bat phone!!!! n n n Hello St Elsewhere’s, Ambulance here. How are

Its the bat phone!!!! n n n Hello St Elsewhere’s, Ambulance here. How are you this fine morning? ……. MICA 16 ETA 33 seconds 87 ♂ Extreme dyspnoea HR 100, BP 200/120

What do you get ready? n n n A Frusemide in big doses B

What do you get ready? n n n A Frusemide in big doses B Tezosentan- The Rep has just visited C Morphine- Everyone knows it’s great for APO D The Bi. PAP machine E The ETT F Your bag, as it’s almost home time

My suggestions n n n A No Frusemide B GTN C More GTN D

My suggestions n n n A No Frusemide B GTN C More GTN D The CPAP machine E Aspirin F Your bag as it’s almost home time

Drowning on dry land! n n Elderly Fluid filled alveolar spaces Lung dysfunction Results

Drowning on dry land! n n Elderly Fluid filled alveolar spaces Lung dysfunction Results in… n n n SOB++ frothy sputum hypoxia diaphoresis often hypertensive

Pathophysiology n n n pulmonary capillary pressure plasma oncotic pressure pulmonary capillary permeability

Pathophysiology n n n pulmonary capillary pressure plasma oncotic pressure pulmonary capillary permeability

Causes of Cardiogenic APO (acute decompensated heart failure) n n n Myocardial ischaemia/infarction Acute

Causes of Cardiogenic APO (acute decompensated heart failure) n n n Myocardial ischaemia/infarction Acute valvular dysfunction Anaemia Arrhythmias Medication non-compliance Dietary, physical or emotional excess Fluid overload- may be iatrogenic Medication adverse effect (neg inotropy of CCB, BB) Myocarditis Pulmonary embolus Progression congestive cardiac failure

Causes of Non-cardiogenic APO n n n n Airway obstruction Asthma Eclampsia Head Injury,

Causes of Non-cardiogenic APO n n n n Airway obstruction Asthma Eclampsia Head Injury, Intracerebral haemorrhage Hyperbaric oxygen treatment Inhalation injury Lung re-expansion. E. g. after treatment of a pneumothorax Near drowning/ cold water immersion Opiates and opiate antagonists (Naloxone and Naltrexone) Pancreatitis Pulmonary embolism (thrombus, fat, amniotic fluid, other) Rapid ascent to high altitude, SCUBA diving Renal/Hepatic failure Sepsis, DIC Shock Toxins

Evaluation n ABC n History n Examination n Investigations

Evaluation n ABC n History n Examination n Investigations

Natriuretic peptides n n BNP (B-type natriuretic peptide) NT-pro BNP(N-terminal pro-BNP) AHF – BNP

Natriuretic peptides n n BNP (B-type natriuretic peptide) NT-pro BNP(N-terminal pro-BNP) AHF – BNP >500 pg/m. L, or NT-pro. BNP >450/900/1800 Other causes if BNP<100 or NT-pro. BNP<450

BNP - Issues n n n Expense Intermediate values False Positives n n PE,

BNP - Issues n n n Expense Intermediate values False Positives n n PE, Sepsis, renal failure, elderly, CHF False Negatives n Early in APO, Obesity, valvular or pericardial dis

Radiology n n Upper Lobe diversion Basilar and hilar infiltrates Kerley B Lines Loss

Radiology n n Upper Lobe diversion Basilar and hilar infiltrates Kerley B Lines Loss of vascular delineation and widespread consolidation

Radiology n Kerley B Lines

Radiology n Kerley B Lines

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Ultrasound

Management - General n n Remove from causative environment Maintain oxygenation Maintain cardiac output

Management - General n n Remove from causative environment Maintain oxygenation Maintain cardiac output Treat underlying cause

Normotensive/Hypertensive Patient n Maximise oxygenation n n Preload and afterload reduction n n NIV

Normotensive/Hypertensive Patient n Maximise oxygenation n n Preload and afterload reduction n n NIV Nitrates (ACEI), Frusemide Others Treat reversible causes

Nitrates n n n Relax smooth muscle Preload at low dose Afterload at higher

Nitrates n n n Relax smooth muscle Preload at low dose Afterload at higher dose Coronary effects Win n n limits Delivery- IV/SL/Top

Other drugs n n Other Vasodilators-SNP ACE Inhibitors n n n Afterload reduction improves

Other drugs n n Other Vasodilators-SNP ACE Inhibitors n n n Afterload reduction improves CO Aspirin

Other drugs n Frusemide n n n Venodilator Diuretic Morphine n n Sympatholysis and

Other drugs n Frusemide n n n Venodilator Diuretic Morphine n n Sympatholysis and anxiolysis ADHERE database - ^ ETT, ICU, mortality Not for routine use If required, use small doses!

Other drugs n Vasodilators n Nesiritide (BNP) n n Levosimendan n n Maybe Serelaxin

Other drugs n Vasodilators n Nesiritide (BNP) n n Levosimendan n n Maybe Serelaxin n n No Nicorandil n n Arterial and venodilator but NOT recommended Maybe Endothelin receptor anatagonists- Tezosentan n No

Ventilatory support n n n High flow Oxygen to all ETT NIV- CPAP and

Ventilatory support n n n High flow Oxygen to all ETT NIV- CPAP and Bi. PAP

NIV n n Oxygen delivery Pulmonary effects Cardiovascular effects Issues n n Tight mask

NIV n n Oxygen delivery Pulmonary effects Cardiovascular effects Issues n n Tight mask PTX

NIV n Use in APO n CPAP Vs Bi. PAP

NIV n Use in APO n CPAP Vs Bi. PAP

NIV Intubation

NIV Intubation

NIV Death

NIV Death

Hypotensive Patient n n Most severe RSI-ETT n n PEEP Invasive monitoring Inotropes -

Hypotensive Patient n n Most severe RSI-ETT n n PEEP Invasive monitoring Inotropes - dobutamine Reperfusion therapy

Essentials High morbidity and mortality n Pathophysiological state n n n Maldistribution of fluid.

Essentials High morbidity and mortality n Pathophysiological state n n n Maldistribution of fluid. Most patients are not fluid overloaded Maintain oxygenation and cardiac output. n Correct reversible causes. n In hypotensive patients. n In normotensive and hypertensive patients n n upright, oxygen, nitrates and CPAP. Nitrates reverse the cause n NIV is safe and effective n

Controversies n. Nitrate dosages n. Bi-PAP n. Frusemide, Morphine n. The role of new

Controversies n. Nitrate dosages n. Bi-PAP n. Frusemide, Morphine n. The role of new agents.

What do you get ready? n n n A Frusemide in big doses B

What do you get ready? n n n A Frusemide in big doses B Tezosentan- The Rep has just visited C Morphine. Everyone knows it’s great for APO D The Bi. PAP machine E The ETT F Your bag, as it’s almost home time

My suggestions n n n A No Frusemide B GTN C More GTN D

My suggestions n n n A No Frusemide B GTN C More GTN D The CPAP machine E Aspirin F Your bag as it’s almost home time